Prediction Score for persisting perfusion defects after pulmonary embolism
Language English Country Czech Republic Media print-electronic
Document type Comparative Study, Journal Article
PubMed
31551608
DOI
10.5507/bp.2019.033
Knihovny.cz E-resources
- Keywords
- classification, perfusion defects, prediction score, pulmonary embolism, reperfusion, risk score,
- MeSH
- Anticoagulants therapeutic use MeSH
- Adult MeSH
- Echocardiography MeSH
- Hemoglobins analysis MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Embolism complications drug therapy MeSH
- Hypertension, Pulmonary drug therapy etiology MeSH
- Clinical Decision Rules * MeSH
- Proportional Hazards Models MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Age Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Names of Substances
- Anticoagulants MeSH
- Hemoglobins MeSH
AIMS: Long-term persistence of perfusion defect after pulmonaryembolism (PE) may lead to the development of chronic thromboembolic pulmonary hypertension. Identification of patients at risk of such a complication using a scoring system would be beneficial in clinical practice. Here, we aimed to derive a score for predicting persistence of perfusion defects after PE. METHODS: 83 patients after PE were re-examined 6, 12 and 24 months after the PE episode. Data collected at the time of PE and perfusion status during follow-ups were used for modelling perfusion defects persistence using the Cox proportional hazards model and validated using bootstrap method. RESULTS: A simple scoring system utilizing two variables (hemoglobin levels and age at the time of PE) was developed. Patients with hemoglobin levels over 140 g/L who were older than 65 years were at the highest risk of perfusion defects; in patients with the same hemoglobin levels and age <65 years, the risk was reduced by 79%, and by 89% in patients with hemoglobin <140 g/L. CONCLUSION: The proposed scoring system may be useful in clinical practice for identifying patients with high risk of persisting perfusion defects, flagging them for closer follow up, thus improving the effectiveness of long-term treatment of patients after PE.
References provided by Crossref.org